Dr. Cory Hugen, M.D. M.S. is a renowned urologic researcher and clinician. He has been the lead or co-investigator on dozens of clinical trials in addition to being a multi-decorated physician serving in the United States Air Force.
Dr. Hugen received medical training at Loyola University Chicago’s Stritch School of Medicine, where he also completed a residency in urology. He joined the U.S. Air Force and served as an attending urologist in San Antonio, Texas as well as Bagram, Afghanistan.
Following his military service, Dr. Hugen completed a Society of Urologic Oncology fellowship at the University of Southern California as well as a master’s degree in clinical, biological, and translational investigations. Before joining City of Hope, he was an Associate Clinical Professor and the Division Chief of Urologic Oncology at the University of California Irvine.
Dr. Hugen has expertise in treating patients with bladder, kidney, testicular, and penile cancers. He was drawn to City of Hope because of its singular focus on providing world-class cancer care. When not working with patients, Dr. Hugen enjoys attending his children’s school and sporting events, exercising, reading, and traveling.
2017, M.S., Keck School of Medicine of USC, Los Angeles, California
2005, M.D., Loyola University Chicago, Stritch School of Medicine, Chicago, Illinois
2001, B.A., Calvin College, Grand Rapids, Michigan
Basic Text Field
2015-2017, Society of Urologic Oncology, Los Angeles County+University of Southern California Medical Center, Los Angeles, California
Basic Text Field
2006-2011, Urology, Loyola University Medical Center, Maywood, Illinois. Edward Hines, Jr. Veterans Affair Hospital, Hines, Illinois
Basic Text Field
2005-2006, Surgery, Loyola University Medical Center, Maywood, Illinois. Edward Hines, Jr. Veterans Affair Hospital, Hines, Illinois
Basic Text Field
2022-present, Associate Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery, City of Hope Orange County, Irvine, California
2021, Associate Clinical Professor of Urology, University of California Irvine, Irvine, California, and Long Beach Memorial Medical Center, Long Beach, California. Long Beach Veterans Affairs Hospital, Long Beach, California
2019-2022, Director, Division of Urologic Oncology, University of California, Irvine, Irvine, California
2017-2022, Assistant Clinical Professor of Urology, University of California, Irvine, Irvine, California,, Long Beach Memorial Medical Center, Long Beach, California, and Long Beach Veterans Affairs Hospital, Long Beach, California
2011-2015, Attending Urologist, San Antonio Military Medical Center, San Antonio, Texas. Audie L. Murphy Veterans Affairs Hospital, San Antonio, Texas. Craig Joint Theater Hospital, Bagram Airfield, Afghanistan
Polcari AJ, Hugen CM, Turk TM. Endoscopic management of upper tract urothelial carcinoma. Canadian Journal of Urology. 2009; 16( 6): 4887-4894
Polcari AJ, Hugen CM, Sivarajan G, Woods ME, Paner GP, Flanigan RC, Quek ML. Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. Journal of Endourology 2009; 23( 8): 1313-1317.
Lopez-Huertas H, Polcari AJ, Hugen CM, Farooq A, Turk TM. A novel technique for the removal of minimally encrusted ureteral stents. Journal of Endourology. 2010; 24( 1): 9-11.
Rao, M, Polcari AJ, Brancato S, Hugen CM, Bresler, L. Mycobacterium bovis prostatic abscess following intravesical BCG therapy. BJUI. 2010. On-line case report.
Polcari AJ, Lopez-Huertas H, Hugen CM, Turk TM. Cost analysis and clinical applicability of the Resonance metallic ureteral stent. Expert Review of Pharmacoeconomics and Outcomes Research 2010; 10(1): 11-15.
Hugen CM, Polcari AJ, Quek ML, Garza RP, Fitzgerald MP, Flanigan RC. Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram. World Journal of Urology 2010; 28(6): 741-4.
Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC. Risk Factors for Recurrence Following Radical Cystectomy for Pathologic Node Negative Bladder Cancer. Journal of Surgical Oncology 2010; 102(4):334-337.
Flanigan RC, Polcari AJ, Hugen CM. Prognostic variables and nomograms for renal cell carcinoma. International Journal of Urology 2011; 18(1):20-31.
Hugen CM, Polcari AJ, Farooq AV, Fitzgerald MP, Holt DR, Milner JE. Size Does Matter: Donor Renal Volume Predicts Recipient Function Following Live Donor Renal Transplantation. Journal of Urology 2011; 185(2):605-9.
Hugen CM, Polcari AJ, Skolek R, Mozes MF, Milner JE. Illinois Statewide Dual Kidney Transplant Experience: Are We Appropriately Selecting Kidneys? Journal of Urology 2011; 186(3):996-1000.
Rao MV, Quek ML, Jayram G, Ellimoottil C, Sondej T, Hugen CM, Flanigan RC, Steinberg GD. Radical Cystectomy after BCG Immunotherapy in Patients with Previous Prostate Radiotherapy. ISRN Urology 2013; Vol 2013 Article ID 405064.
Svatek RS, Zhao XR, Morales EE, Jha MK, Tseng TY, Hugen CM, Hurez V, Hernandez J, Curiel TJ. Sequential Intravesical Mitomcyin Plus Bacillus Calmette-Guerin for Non-muscle Invasive Urothelial Bladder Carcinoma: Translation and Phase I Trial. Clinical Cancer Research 2015;21(2):303-11.
Hugen CM, Daneshmand S. Orthotopic Urinary Diversion in the Elderly. World Journal of Urology. 2016;34:13-18.
Bazargani ST, Djaladat H, Schuckman AK, Hugen CM, Daneshmand S. Blue Light Cystoscopy with Cysview: The USC Experience, J Endourol Part B Videourology. DOI: 10.1089/vid.2015.0054.
Hugen CM, Daneshmand S. Lymph node dissection in bladder cancer – where do we stand? World Journal of Urology. 2017 Apr;35(4):527-533
Hugen CM, Hu B, Jeldres C, Burton C, Nichols CR, Porter CR, Daneshmand S. Utilization of RPLND for testicular cancer in the United States: Results from the National Cancer Data Base (1998-2011). Urologic Oncology. 2016;34(11):e487.
Hugen CM, Duddalwar V, Daneshmand S. Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy. CurrentUrology Reports. 2016:17:62.
Hugen CM, Zainfeld D, Goldkorn A. Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine. Front Oncol. 7:6.
Clifford, T, Burg ML, Hu B, Loh-Doyle J, Hugen CM, Cai J, Djaladat H, Wayne K, Daneshmand S. Satisfaction with Testicular Prosthesis after Radical Orchiectomy. Urology. 2018 Apr; 114:128-132.
Bazargani ST, Djaladat H, Schuckman AK, Hugen CM, Daneshmand S. Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesion. Videourology (New Rochelle). 2018 Apr 6; 32(2).
Amini E, Ahmadi N, Clifford TG, Hugen CM, Bazargani ST, Cai J, Miranda G, Sherrod AE, Daneshmand S, Djaladat H. Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy. Int Urol Nephrol. 2019 Mar; 51(3):435-441.
Djaladat H, Ghoreifi A, Basin M, Hugen CM, Aslzare M, Miranda G, Hwang D, Schuckman A, Aron M, Thangathurai D, Duddalwar V, Daneshmand S. Perioperative Outcome of Suprarenal Resection of Vena Cava without Reconstruction in Urologic Malignancies: A Case Series and Review of the Literature. Urology. 2020 Aug;142: 146-154.
Ratings & Reviews
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Know important info medical history
Show respect for what you say
Spend enough time with you
Rate provider 0-10
Recommend this provider office
Provider explain in way you understand
Provider listen carefully to you
I was very pleased with the provider and the personnel professionalism. - Verified patient
He is gentle and caring. No one better!!! Appreciate him so very much and I have full confidence in him. - Verified patient
Very professional and caring - Verified patient
Very respectful and showed empathy. - Verified patient